Innovating Treatments To Address the Global Public Health Burden of Infectious Diseases.
Qpex Biopharma, now a Shionogi Group Company, is a resistance-focused infectious disease company developing a pipeline of novel antibiotics and anti-infectives targeting drug-resistant bacterial pathogens. The company focuses on developing clinically proven treatments for critically resistant gram-negative organisms, addressing the global public health crisis of antimicrobial resistance. Qpex has partnered with BARDA to advance its antibiotic portfolio.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account